Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection

A global method is proposed for therapeutic drug monitoring of atazanavir, a novel protease inhibitor and of all other protease inhibitors (PI) and non nucleoside reverse transcriptase inhibitors (NNRTI) which are currently used to treat HIV patients. All drugs are extracted after a liquid–liquid ex...

Full description

Saved in:
Bibliographic Details
Published in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2004-12, Vol.813 (1), p.353-358
Main Authors: Dailly, E., Raffi, F., Jolliet, P.
Format: Article
Language:English
Subjects:
Amprenavir
Analysis
Analytical, structural and metabolic biochemistry
Atazanavir
Atazanavir Sulfate
Biological and medical sciences
Chromatography, High Pressure Liquid - methods
Efavirenz
Fundamental and applied biological sciences. Psychology
General pharmacology
HIV Protease Inhibitors - blood
Humans
Indinavir
Lopinavir
Medical sciences
Nelfinavir
Nevirapine
Oligopeptides - blood
Pharmacology. Drug treatments
Pyridines - blood
Reproducibility of Results
Ritonavir
Saquinavir
Sensitivity and Specificity
Spectrophotometry, Ultraviolet - methods
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A global method is proposed for therapeutic drug monitoring of atazanavir, a novel protease inhibitor and of all other protease inhibitors (PI) and non nucleoside reverse transcriptase inhibitors (NNRTI) which are currently used to treat HIV patients. All drugs are extracted after a liquid–liquid extraction and separated on a C18 column with a binary gradient elution except lopinavir which is separated without this gradient. The absorbance is measured at 259 nm except for lopinavir (205 nm) and nevirapine (320 nm). This method is specific, accurate, precise (the intra-day and inter-day imprecision and inaccuracy are lower than 15%) and the limits of quantitation (0.40 mg/L for nevirapine, 0.10 mg/L for indinavir, 0.10 mg/l for M8, 0.05 mg/L for amprenavir, 0.10 mg/L for nelfinavir, 0.10 mg/L for saquinavir, 0.10 mg/L for ritonavir, 0.10 mg/L for efavirenz, 0.10 mg/L for atazanavir and 0.20 mg/L for lopinavir) are consistent with trough plasma concentrations allowing to use this method for therapeutic drug monitoring of PI and NNRTI.
ISSN:1570-0232
1873-376X
DOI:10.1016/j.jchromb.2004.10.005